Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-19

Clinical Trial Update: Effect of Papaverine on Renal Artery Blood Flow Volume [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of papaverine on renal artery blood flow volume in kidney cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Papaverine (papaverine)

Snippet

Sponsor: Asan Medical Center | Conditions: Kidney Cancer | Phase 4 | Status: COMPLETED